Molecular Biology Terms Starting With U
Molecular Biology Glossary: U
Jump to Molecular Biology Term
Ubiquitin
/ yoo-BIK-wih-tin / · Latin ubique, everywhere; -in, protein suffix
Ubiquitin is a small 76-amino-acid protein found in all eukaryotic cells that covalently attaches to other proteins as a post-translational tag, directing them to the proteasome for degradation or altering their activity and interactions.
Ubiquitin is among the most conserved proteins known: the sequences from baker’s yeast (Saccharomyces cerevisiae) and humans differ at only three of 76 positions, reflecting intense selective pressure on every residue. Three classes of enzymes, designated E1 activating enzymes, E2 conjugating enzymes, and E3 ligases, work in a sequential cascade to attach ubiquitin to a lysine residue on the target protein. The E3 ligase confers substrate specificity, and the human genome encodes more than 600 distinct E3 ligases, each recognizing a defined set of targets.
Polyubiquitin chains linked through lysine 48 of ubiquitin typically direct proteins to the 26S proteasome, whereas chains linked through lysine 63 regulate DNA repair and endosomal sorting without triggering degradation.
The word "ubiquitin" was coined by Gideon Goldstein in 1975 because the protein appeared in every eukaryotic tissue examined. Aaron Ciechanover, Avram Hershko, and Irwin Rose received the 2004 Nobel Prize in Chemistry for discovering how ubiquitin marks proteins for degradation, a finding that transformed understanding of intracellular protein turnover.
Ubiquitin tagging occurs only in diseased or stressed cells. Ubiquitination proceeds continuously in healthy cells, turning over thousands of short-lived regulatory proteins every minute to maintain normal cell-cycle progression, signaling, and protein quality control.
HIV uses the host ubiquitin system to disable an antiviral defense: the viral protein Vif recruits a cellular E3 ligase to attach ubiquitin chains to APOBEC3G, a host enzyme that would otherwise mutate the viral genome. Without this ubiquitin-mediated degradation of APOBEC3G, HIV replication drops by more than 1,000-fold in certain T cell lines.
Ubiquitination
/ yoo-bik-wih-tih-NAY-shun / · Latin ubique (everywhere) + -ation (process)
Ubiquitination is the covalent attachment of one or more ubiquitin molecules to a lysine residue of a substrate protein, marking it for proteasomal degradation or modifying its activity, localization, or protein interactions.
Ubiquitination proceeds through a three-enzyme cascade in which an E1 activating enzyme first forms a high-energy thioester bond with ubiquitin, then transfers it to an E2 conjugating enzyme, and finally an E3 ligase catalyzes transfer to the substrate. Polyubiquitin chains linked through lysine 48 of ubiquitin direct substrates to the 26S proteasome for degradation, while chains linked through lysine 63 coordinate DNA damage responses and vesicle trafficking without triggering proteolysis. Monoubiquitination, the attachment of a single ubiquitin, regulates histone function and receptor endocytosis rather than protein destruction.
The human genome encodes only two E1 enzymes but more than 600 E3 ligases, reflecting the enormous specificity required to tag the right proteins at the right time.
Ubiquitination was first characterized as a degradation signal, but researchers discovered in the 1990s that monoubiquitination of histone H2A at lysine 119 represses gene transcription without destroying the histone. This modification, deposited by the Polycomb repressive complex 1, now ranks among the best-studied epigenetic marks in mammalian development.
Ubiquitination always destroys the protein it marks. The outcome depends entirely on the chain linkage type: lysine-48-linked chains send proteins to the proteasome, while lysine-63-linked chains and monoubiquitin signals change protein behavior without degradation.
The tumor suppressor p53 is continuously ubiquitinated by the E3 ligase MDM2, which targets p53 for proteasomal degradation and keeps p53 protein levels low in unstressed cells. DNA damage disrupts the MDM2-p53 interaction, and p53 levels rise within minutes, with the protein accumulating to concentrations five to ten times above baseline in irradiated human cells.
UTR
/ YOO-TEE-AR / · Acronym: Untranslated Region
UTR is a non-coding segment at the 5' or 3' end of a mature mRNA molecule that regulates translation efficiency, mRNA stability, and subcellular localization without itself encoding protein.
The 5′ UTR lies between the 5′ cap and the AUG start codon and can contain internal ribosome entry sites, upstream open reading frames, and secondary structures that modulate ribosome binding. Its median length in human mRNAs is about 200 nucleotides, and even small structural changes within it can reduce translation by more than tenfold. The 3′ UTR follows the stop codon and harbors AU-rich elements, microRNA binding sites, and polyadenylation signals that collectively determine mRNA half-life and where in the cell the transcript is translated.
Mutations in UTRs are increasingly recognized as disease-causing variants that alter expression of otherwise normal coding sequences; a single point mutation in the 5′ UTR of the THPO gene, for example, removes an upstream open reading frame and causes hereditary thrombocythemia by dramatically increasing thrombopoietin production.
The 3' UTR of the nanos gene in the fruit fly (Drosophila melanogaster) contains localization signals that restrict Nanos protein to the posterior pole of the embryo. This spatial restriction is so precise that mislocalization of nanos mRNA disrupts the entire anterior-posterior body axis of the developing larva.
Untranslated regions carry no regulatory information and exist only as spacers between the coding sequence and the ends of the transcript. UTRs contain binding sites for regulatory proteins and microRNAs that can change how much protein a cell produces from an otherwise identical coding sequence.
The 3' UTR of the human HIF1A mRNA contains binding sites for miR-20b and miR-199a, which reduce HIF-1 alpha protein levels under normal oxygen conditions. Under hypoxia, expression of these microRNAs drops, and HIF-1 alpha protein accumulates to levels roughly three to five times higher than those seen in normoxic cells, triggering the cellular response to low oxygen.